CD33 is also expressed in myelodysplastic syndrome and chronic myelomonocytic leukemia [40] An ongoing trial targeting CD33 expressing myeloid-derived suppressor cells using the same antibody described in this article is ongoing [41]. This evidence concerns the gene CD33 and myelodysplastic syndrome.